| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.17 | 7e-06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.21 | 6e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.21 | 6e-05 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |